cdmo.directory
← Compare landing

Advaxia vs Synthego

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/advaxia/synthego

CategoryAdvaxiaSynthego
Listed sitecdmocdmo
SummarycGMP CDMO specializing in adenovirus vaccine development and manufacturing with a 100% batch approval rate and 10+ years of biologics expertise, serving major pharmaceutical and biotech clients.Synthego manufactures GMP-grade CRISPR components and molecular biology reagents for clinical and research applications, with 19 INDs cleared and 200+ clinical sgRNA batches produced.
Services
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Vaccine Manufacturing
  • Viral Vector Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Vaccine
  • Gene Therapy
  • Gene Therapy
  • Cell Therapy
Indications
  • Infectious Disease
Data not yet provided.
Locations
  • Headquarters & Manufacturing Facility, Rome, Lazio, Italy
Data not yet provided.
Certifications
  • EMA · Identifier: EMA compliant
  • FDA · Identifier: FDA compliant
  • AIFA · Identifier: AIFA compliant
  • ISO · Identifier: ISO 14.001
  • ISO · Identifier: ISO 45.001
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.